EUVIMEDEUVIMED entdecken
Crossref

MDM2/p53-based live-cell quantitative FRET imaging for apoptosis drug discovery

Zhiyu Xiao, Lingmin Xie, Ziru Wu, Xinghong Cai, Zhengfei Zhuang, Tongsheng Chen

Methods · 2026

DOI: 10.1016/j.ymeth.2025.12.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods, 2026. Verfasst von Zhiyu Xiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Laser Life Science & Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, School of Optoelectron…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Tumor Suppressor Protein p53, Apoptosis, Fluorescence Resonance Energy Transfer. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Guangdong Special Support Plan, Natural Science Foundation of Guangdong Province, South China Normal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting the interaction between P53 and MDM2 to re-activate P53 to induce apoptosis is an important strategy for cancer treatment. In this study, based on the unique advantages of in situ visualization, dynamic imaging, and quantitative analysis of living cell FRET imaging, a method for screening apoptotic drugs targeting p53-MDM2 interaction was developed. A stable model of Nutlin-3-induced apoptosis was established in MCF-7 cells, which was verified by reducing mitochondrial membrane potential and increasing the proportion of nuclear chromatin condensation (from 9.16 % to 50.55 %). Biochemical methods such as WB analysis found that after activating P53, BAX expression was up-regulated through a Puma-independent pathway, which promoted BAX oligomerization. Live-cell quantitative FRET imaging found that the maximum donor center FRET efficiency (EDmax) of CFP-p53 and YFP-MDM2 decreased from 0.50 to 0.22 after Nutlin-3 treatment, and the co-localization coefficient decreased significantly from 83 % to 22 %, confirmed that Nutlin-3 directly disrupted the interaction between P53/MDM2, promoting P53 nuclear translocation and apoptosis. This indicated that Nutlin-3 was a direct inhibitor of the P53/MDM2 interaction. Apoptosis drug screening was performed in MCF-7 cells, and we found that the EDmax was 0.29 and 0.31 for the cells treated with DOX and RSV, respectively, and 0.48 for the IKE-treated cells and 0.43 for the SOR-treated cells, indicating that DOX and RSV, but not IKE and SOR, were potential P53/MDM2-dependent apoptotic drugs. In addition, Nutlin-3 treatment decreased the EDmax value in p53 wild-type U2OS cells from 0.43 to 0.20. In summary, our method can identify p53-MDM2 interaction inhibitors in living cells, providing a quantitative in vivo supplement for traditional target-based drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53ApoptosisFluorescence Resonance Energy TransferDrug DiscoveryHumansPiperazinesImidazolesMCF-7 CellsAntineoplastic Agentsbcl-2-Associated X ProteinProtein Binding

Stichwörter der Autor:innen

Drug discoveryFRETMDM2P53

Substanzen

Proto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53nutlin 3PiperazinesImidazolesMDM2 protein, humanTP53 protein, humanAntineoplastic Agentsbcl-2-Associated X Protein

Autor:innen und Institutionen

  • MOE Key Laboratory of Laser Life Science & Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, School of Optoelectronic Science and Engineering, South China Normal University, Guangzhou 5…

Förderung

  • Guangdong Special Support Plan
  • Natural Science Foundation of Guangdong Province
  • South China Normal University
  • Key Technologies Research and Development Program of Guangzhou
  • National Natural Science Foundation of China
  • Special Project for Research and Development in Key areas of Guangdong Province

Zitieren

APA

Xiao, Z., Xie, L., Wu, Z., Cai, X., Zhuang, Z., & Chen, T. (2026). MDM2/p53-based live-cell quantitative FRET imaging for apoptosis drug discovery. Methods. https://doi.org/10.1016/j.ymeth.2025.12.002

Vancouver

Xiao Z, Xie L, Wu Z, Cai X, Zhuang Z, Chen T. MDM2/p53-based live-cell quantitative FRET imaging for apoptosis drug discovery. Methods. 2026. doi:10.1016/j.ymeth.2025.12.002

BibTeX
@article{Xiao2026,
  author = {Xiao, Zhiyu and Xie, Lingmin and Wu, Ziru and Cai, Xinghong and Zhuang, Zhengfei and Chen, Tongsheng},
  title = {MDM2/p53-based live-cell quantitative FRET imaging for apoptosis drug discovery},
  journal = {Methods},
  year = {2026},
  doi = {10.1016/j.ymeth.2025.12.002}
}
Kostenlos starten →